TUMORIGENICITY OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED CELL-LINES IN SEVERE COMBINED IMMUNODEFICIENT MICE AND CHARACTERIZATION OF THE CELLS PROLIFERATING IN-VIVO
TUMORIGENICITY OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED CELL-LINES IN SEVERE COMBINED IMMUNODEFICIENT MICE AND CHARACTERIZATION OF THE CELLS PROLIFERATING IN-VIVO
复制标题
DOI:
10.1182/blood.v86.6.2350.bloodjournal8662350
复制
发表时间:
1995-09-15
期刊:
影响因子:
20.3
通讯作者:
UCHIYAMA, T
中科院分区:
文献类型:
--
作者:
IMADA, K;TAKAORIKONDO, A;UCHIYAMA, T
The mechanism involved in leukemogenesis and neoplastic cell growth of adult T-cell leukemia (ATL) still remains unclear, We examined the tumorigenicity of human T-cell leukemia virus type I (HTLV-I)-infected cell lines in an in vivo cell proliferation model using severe combined immunodeficient (SCID) mice. Eleven HTLV-I-infected cell lines were injected into SCID mice and we found that 4 of them were capable of proliferating in SCID mice. Three of four transplantable cell lines are derived from the leukemic cell clone and 6 of 6 HTLV-I-infected cell lines of nonleukemic cell origin could not engraft in SCID mice. Interestingly, it was shown that some HTLV-I-infected and interleukin-2 (IL-2)-dependent cell lines could successfully engraft in SCID mice. The expression of IL-2 mRNA was not detected in these cell lines growing either in vivo or in vitro. HTLV-I viral products were not detected in 3 of 4 transplantable cell lines proliferating in vivo. Peripheral blood T cells immortalized by introduction of tax gene of HTLV I were found to have no tumorigenic potential in SCID mice. These data suggest that (1) HTLV-I-infected cell lines of nonleukemic cell origin do not have enough leukemogenic changes to acquire the tumorigenic potential in SCID mice; (2) the IL-2 autocrine mechanism is not directly involved in the tumor cell growth; (3) viral gene expression is not needed for the maintenance of neoplastic cell growth; and (4) the expression of tax gene is not sufficient for the neoplastic cell growth in vivo. (C) 1995 by The American Society of Hematology.